Impli awarded £1.4M NIHR grant to advance world-first continuous hormone monitoring
The award will fund a 30-month consortium programme bringing together PHTA-based Impli, Imperial College Healthcare NHS Trust, King’s College London, and Fertility Europe to take the BEAM biosensor from prototype to first-in-human clinical validation. Impli, the deep-tech company developing the first continuous molecular monitoring platform for hormonal health at PHTA, has been awarded a £1.4 […]